Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP825334.RA-qDK8hTP8DJSZXGMXR3itecM-A28QkGD_zQpc8RnDRo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP825334.RA-qDK8hTP8DJSZXGMXR3itecM-A28QkGD_zQpc8RnDRo130_assertion type Assertion NP825334.RA-qDK8hTP8DJSZXGMXR3itecM-A28QkGD_zQpc8RnDRo130_head.
- NP825334.RA-qDK8hTP8DJSZXGMXR3itecM-A28QkGD_zQpc8RnDRo130_assertion description "[Ack1 Tyr284 phosphorylation is prognostic of progression of prostate cancer and inhibitors of Ack1 activity could be novel therapeutic agents to treat AIPC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825334.RA-qDK8hTP8DJSZXGMXR3itecM-A28QkGD_zQpc8RnDRo130_provenance.
- NP825334.RA-qDK8hTP8DJSZXGMXR3itecM-A28QkGD_zQpc8RnDRo130_assertion evidence source_evidence_literature NP825334.RA-qDK8hTP8DJSZXGMXR3itecM-A28QkGD_zQpc8RnDRo130_provenance.
- NP825334.RA-qDK8hTP8DJSZXGMXR3itecM-A28QkGD_zQpc8RnDRo130_assertion SIO_000772 20623637 NP825334.RA-qDK8hTP8DJSZXGMXR3itecM-A28QkGD_zQpc8RnDRo130_provenance.
- NP825334.RA-qDK8hTP8DJSZXGMXR3itecM-A28QkGD_zQpc8RnDRo130_assertion wasDerivedFrom befree-2016 NP825334.RA-qDK8hTP8DJSZXGMXR3itecM-A28QkGD_zQpc8RnDRo130_provenance.
- NP825334.RA-qDK8hTP8DJSZXGMXR3itecM-A28QkGD_zQpc8RnDRo130_assertion wasGeneratedBy ECO_0000203 NP825334.RA-qDK8hTP8DJSZXGMXR3itecM-A28QkGD_zQpc8RnDRo130_provenance.